We use cookies to improve your experience. By your continued use of this site you accept such use.
Takeda Pharmaceutical Company Limited

  • Multimedia content

  • Images (2)
    • Giles Platford, president, Emerging Markets, Takeda (right) and Dr. Kibachio Joseph Mwangi (left), Head: Division of Non-Communicable Diseases, Ministry of Health, at the launch of Takeda’s bold, new Access to Medicines strategy
    • Takeda’s Access to Medicines strategy in Sub-Saharan Africa will include a long-term partnership with the Pan African Heart Foundation to create a mobile screening program for hypertension – a leading cause of cardiovascular disease in the region – and diabetes in select local counties in Kenya, including Kajiado county
  • Links (1)
  • All (3)
Source: Takeda Pharmaceutical Company Limited |

Takeda Announces Bold, New Access to Medicines for Sub-Saharan Africa from Nairobi

Announcement made on the sidelines of TICAD VI

Takeda Pharmaceutical Company Limited (TSE: 4502) (www.Takeda.com) today announced the launch of a bold, new Access to Medicines (AtM) strategy, aimed at increasing access to its innovative and potentially life-saving medicines for patients with some of the highest unmet medical needs. For decades, the company has provided product, funding and access…